Quant Mid Cap Fund: Short-Term Beat, Long-Term Lag

Recent returns should never be the basis for judging whether a mid-cap fund has genuinely recovered, said Bharath Rathore, Executive Director at Anand Rathi Wealth. He was speaking about Quant Mid Cap Fund, which has beaten its benchmark over the last 3 and 6 months after years of lagging. The fund underperformed the benchmark over the last 1, 3, and 5 years, according to the July 2026 factsheet.

Rathore attributed the weaker long-term record to stock selection and portfolio positioning. Quant AMC runs a high-conviction, high-turnover strategy. The fund frequently reshapes its holdings based on an internal framework. That approach can underperform when market trends do not favor the fund's picks. It can also generate strong alpha when those positions start working, Rathore said. A fund manager change in February 2025 may have contributed to a transition phase.

Over the past year, the fund reduced exposure to Reliance Industries while raising stakes in Tata Communications and Aurobindo Pharma. Healthcare, basic materials, and technology became the main drivers of the 6-month outperformance.

The short-term bounce raises a natural question: is this a genuine recovery or a temporary rebound? Rathore said investors should look beyond recent numbers. He advised focusing on consistency in rolling returns, sustained alpha generation over the benchmark, improvements in portfolio quality, and stronger risk-adjusted performance measured by the Sharpe ratio and Jensen's Alpha.

Rathore said investors should consider reducing exposure only if mid caps have become an outsized share of the portfolio, such as 70% to 80% of equity allocation. Exiting a fund makes sense only if underperformance persists across multiple market cycles, the fund manager or investment philosophy changes, or peers consistently deliver better risk-adjusted returns.

"Recent performance alone should never be the basis for judging whether a mid-cap fund has genuinely recovered," Rathore said.